Dr. Xingmin Sun is an Associate Professor with tenure in the Department of Molecular Medicine, College of Medicine at the University of South Florida (USF). He holds courtesy appointments in the Department of Internal Medicine, Department of Cell Biology, Microbiology & Molecular Biology, Department of Chemistry at USF, and USF Genomics. He received his PhD in Natural Sciences from the University of Kiel, Germany, and his master’s degree in Veterinary Microbiology and Immunology from Nanjing Agricultural University, China. He received his postdoctoral training in Molecular Microbiology and Biochemistry at Brown University, USA. He was an NIH (National Institutes of Health) Career Development K01 Awardee. His laboratory has been continuously supported by NIH. He has been actively serving NIH study section panels including chairing the NIH study section panel in 2020. Currently, he serves as an Associate Editor for “Molecular Medicine”, Associate topic editor for “Frontiers in Microbiology”, and editorial boards for “Infection and Immunity” and “Applied and Environmental Microbiology”. He received the “Tufts Institute for Innovation Inaugural Award” in 2014. He chaired the Research Committee of College of Medicine at USF from 2019 to 2020. In 2018, he was awarded the "Faculty Outstanding Research Achievement Award" at USF. In 2019, he was awarded the "Excellence in Innovation Award" at USF. The research in his laboratory at USF is focused on the pathogenesis of Clostridioides difficile and the development of novel therapeutics including vaccines to prevent / treat C. difficile infection (CDI). C. difficile is a Gram-positive, spore-forming and toxin-producing anaerobic bacterium. It is the most common cause of nosocomial antibiotic-associated diarrhea and the etiologic agent of life-threatening pseudomembranous colitis in the developed world. In the US, C. difficile infection (CDI) caused 223,900 estimated hospitalizations,12,800 deaths and $5 billion healthcare costs in 2017. More alarmingly, C. difficile is classified as an “urgent antibiotic resistant threat” by the Centers for Disease Control and Prevention (CDC). To address these challenges, Sun lab is focusing on following research directions: Antibiotic resistance, physiology, virulence, toxin-antitoxin, two-component systems of C. difficile Innate immune responses to CDI) Development of novel antimicrobials and therapeutics including vaccines against CD

Dr. Daniela Capdepon is one of our highly qualified and best expert Oncologist - Onco Hematologist with an invaluable experience of over 15 years. She is working as an expert Oncologist in Campana Cancer Center. She has completed MEDICINE for her training and expertise. Her residence is in Campana, Buenos Aires, Argentina. She fluently communicates with the patients in Spanish and English. Highly recommended.

Abd El Aziz Nour has completed his PhD in rumen microbiology 1976 from Alexandria University. He worked at Alexandria University as Demonstrator (1976-1981), Associate Professor (1981-1986), Professor (1986-2007), head of the Department of Animal and Fish Production (1999-2002) and Emeritus professor (2007 till now). As recognized leader in his field, he has an extended list of more than 230 publications in international and local Journals and conferences focus on :- 1- manipulation of rumen fermentation for microbial protein synthesis, 2-evaluation of aquatic microalgae as a natural food for filter feeding fish,3-biofloc technology in intensive tilapia farming, and 4-culture of marine microalgae for biofuel production.

Lidia Sas-Paszt currently working as Professor of Biotechnology in Lodz, Lodzkie, in Poland she has experience in research. Her projects and R&D projects have Collaborations from various organizations located in Poland and other International Destinations. Research achievements in implementation of R& D results: studies in the area of rhizosphere and nutrient management strategies in fruit and vegetable crops, development of microbial inocula and bioproducts for horticultural production.

Marwa M. Elmaghrabi Recently she works as a researcher at Microbiology Department, king Saud University, P. O. Box 51178, Riyadh 11543, Saudi Arabia. In addition, she is a permanent researcher of stem cells and tissue culture labs at Center of Excellence for Research in Regenerative Medicine and Applications, Faculty of Medicine, Alexandria University, Egypt. She has been appointed as a Middle East ambassador in consortium publisher Canada Journal of Molecular cell biology. Besides, she is a consultant in field of medical tests underway registration number (73717). Elmaghrabi accumulated 13 years of experience in infection control in healthcare organizations. She participated in many global and international conferences as speaker, moderator, and onsite organizer in Egypt, Canada, and United States of America. Research Gate: https://www.researchgate.net/profile/Marwa-Elmaghrabi